Johnny Jean-Baptiste

Learn More
OBJECTIVES To validate vascular endothelial growth factor receptor-1 (VEGFR1) single nucleotide polymorphism (SNP) rs9582036 as a potential predictive biomarker in metastatic clear-cell renal cell carcinoma (m-ccRCC) patients treated with sunitinib. MATERIALS AND METHODS m-ccRCC patients receiving sunitinib as first-line targeted therapy were included. We(More)
  • 1